Allergy Therapeutics plc (AGY.L) LSE
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Allergy Therapeutics plc
Address
Dominion Way
Worthing, BN14 8SA
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 1903 844 700
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
612
First IPO Date
October 11, 2004
Key Executives
| Name | Title | Pay | Year Born |
| Manuel Llobet | Chief Executive Officer & Executive Director | 504,343 | 1965 |
| Shaun Antony Furlong | Chief Financial Officer & Executive Director | 314,024 | 1976 |
| Matthew Heath | Principal Scientist | 0 | N/A |
| Simon Piggott | Head of Clinical Science | 0 | N/A |
| Russell Picket | Group Financial Controller | 0 | N/A |
| Sue Baker | Head of Human Resources | 0 | N/A |
| Murray Skinner | Chief Scientific Officer | 0 | N/A |
| Alan Bullimore | Head of Communication & Market Development | 0 | N/A |
| Helge Weiner-Trapness | Chief Strategy Officer & Director | 0 | 1963 |
| Karley Charlotte Mouatt Cheesman | Company Secretary | 0 | N/A |
Description
Allergy Therapeutics plc is a biotechnology firm dedicated to the research and development of innovative treatments for allergies. The company offers a range of injectable and sublingual immunotherapies specifically targeting allergens, alongside diagnostic tools and prescription solutions for pollen-related allergies, including those caused by grasses, weeds, and trees. Its diverse product portfolio features Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. Furthermore, Allergy Therapeutics is actively advancing new vaccine candidates designed to address sensitivities to trees, grass, house dust mites, animal dander, and peanuts. With operations spanning Central Europe, Southern Europe, the United Kingdom, and various other international markets, Allergy Therapeutics plc was established in 2004 and is headquartered in Worthing, UK.
